Immunefi vs Chainlink — how do they compare? Immunefi trades at Rp24.67 (market cap Rp27,03M, Rp39,91M 24h volume), while Chainlink trades at Rp157,523 (market cap Rp117,46T, Rp3,85T 24h volume). The key difference: Chainlink is far larger — about 4345542× Immunefi's market cap, and Immunefi's circulating supply is 873,4M / 10B IMU (9%) versus 748,1M / 1B LINK (75%) for Chainlink. Which is the better fit depends on your goals — on Pluang, investors hold Immunefi for 5 Days and Chainlink for 62 Days on average.
| IMU | LINK | |
|---|---|---|
Market Cap | Rp27,03M | Rp117,46T |
Volume (24h) | Rp39,91M | Rp3,85T |
Circulating Supply | 873,4M / 10B IMU (9%) | 748,1M / 1B LINK (75%) |
Typical Hold Time | 5 Days | 62 Days |
Signals from Pluang's Aura AI — not financial advice
Immunefi (IMU) presents a unique crypto asset with a modest market cap of Rp27.03M and only 9% circulating supply, indicating significant token lockup. The 5-day average hold time suggests short-term trading activity. Current technical analysis is limited due to missing price data, but the low circulation rate and small market cap point to high volatility potential. Recent news coverage appears to focus on corporate equity analysis rather than blockchain fundamentals, creating information asymmetry for crypto investors.
Overall outlook remains speculative with limited fundamental data. Key opportunity lies in potential token unlocks and ecosystem growth, while major risks include extreme volatility from low liquidity, regulatory uncertainty, and lack of clear crypto-specific utility. Investors should approach with caution given the asset's early stage and limited market data availability.
Chainlink (LINK) trades at Rp156,107 with a market cap of Rp117.15T, showing bullish technical signals with strong moving average support and neutral oscillators. The token maintains 75% circulation of its 1M max supply, with an average hold time of 62 days. Recent positive developments include former Chainlink executive Taylor Lindman joining the SEC Crypto Task Force, potentially benefiting crypto regulatory clarity. Technical analysis indicates support at Rp148,583 and resistance at Rp157,143, with RSI suggesting mild overbought conditions.
Overall outlook remains cautiously optimistic given strong technical momentum and regulatory tailwinds. Key opportunities include Chainlink's crucial role in blockchain interoperability and real-world data integration. Major risks include regulatory uncertainty, high volatility, and potential profit-taking near resistance levels. Investors should monitor support levels and regulatory developments closely.
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
Immunefi is a security-focused ecosystem token designed to reward contributions to blockchain safety. It aligns protocols, researchers, and communities through bug bounties, staking, and governance incentives. The ecosystem also integrates AI to enhance threat detection and scale protection as the on-chain economy grows.
Read more on IMU →Founded in 2017 by Sergey Nazarov , Chainlink is a blockchain abstraction layer that enables universally connected smart contracts. Through a decentralized oracle network, Chainlink allows blockchains to securely interact with external data feeds, events and payment methods, providing the critical off-chain information needed by complex smart contracts to become the dominant form of digital agreement.
Read more on LINK →